← All companies

HUMA

Humacyte, Inc.

HUMA Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$0.69

+0.01 +1.57%

Key statistics

from XBRL data in SEC filings

Market cap ⓘ

$192M

Revenue (TTM) ⓘ

$2.12M

Net income (TTM) ⓘ

-$96.7M

EPS (TTM) ⓘ

$-0.55

P/E ratio ⓘ

—

Dividend yield ⓘ

—

Free cash flow ⓘ

-$106M

Cash ⓘ

$79.9M

Total assets ⓘ

$138M

Gross margin ⓘ

—

52-week range ⓘ

$0.53 – $2.55

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-06-30 Aug 12, 2026

8-K Results of operations (earnings release) Aug 12, 2026

8-K Delisting notice or listing-rule failure Jul 31, 2026

8-K Entered a material agreement; Regulation FD disclosure Jun 11, 2026

8-K Other events Jun 10, 2026

8-K Amended charter or bylaws; Shareholder vote results Jun 9, 2026

8-K Other events Jun 5, 2026

10-Q Quarter ended 2026-03-31 May 13, 2026

8-K Delisting notice or listing-rule failure May 8, 2026

8-K Entered a material agreement; Regulation FD disclosure Apr 24, 2026

10-K Fiscal year ended 2025-12-31 Mar 27, 2026

8-K Entered a material agreement; Regulation FD disclosure Mar 19, 2026

8-K Results of operations (earnings release); Other events Mar 19, 2026

8-K Entered a material agreement Dec 16, 2025

8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Dec 15, 2025

8-K Terminated a material agreement Dec 15, 2025

8-K Terminated a material agreement Nov 26, 2025

10-Q Quarter ended 2025-09-30 Nov 12, 2025

8-K Results of operations (earnings release) Nov 12, 2025

8-K Entered a material agreement; Regulation FD disclosure Oct 7, 2025

8-K Entered a material agreement; Took on a direct financial obligation Sep 18, 2025

10-Q Quarter ended 2025-06-30 Aug 11, 2025

8-K Results of operations (earnings release) Aug 11, 2025

8-K Amended charter or bylaws; Shareholder vote results Jun 11, 2025

10-Q Quarter ended 2025-03-31 May 13, 2025

8-K Results of operations (earnings release) May 13, 2025

8-K Regulation FD disclosure Apr 18, 2025

10-K Fiscal year ended 2024-12-31 Mar 31, 2025

8-K Results of operations (earnings release) Mar 28, 2025

8-K Regulation FD disclosure Mar 27, 2025

8-K Entered a material agreement; Regulation FD disclosure Mar 26, 2025

8-K Other events Mar 25, 2025

8-K Regulation FD disclosure; Other events Dec 20, 2024

8-K Entered a material agreement; Regulation FD disclosure Nov 14, 2024

10-Q Quarter ended 2024-09-30 Nov 8, 2024

8-K Results of operations (earnings release) Nov 8, 2024

8-K Other events Oct 28, 2024

8-K Entered a material agreement; Regulation FD disclosure Oct 7, 2024

8-K Entered a material agreement Sep 25, 2024

10-Q Quarter ended 2024-06-30 Aug 13, 2024